| 注册
首页|期刊导航|中国临床医学|免疫抑制宿主并发肺部感染的临床诊治进展

免疫抑制宿主并发肺部感染的临床诊治进展

邝中淑 赵英珺 宋振举

中国临床医学2018,Vol.25Issue(1):137-140,4.
中国临床医学2018,Vol.25Issue(1):137-140,4.DOI:10.12025/j.issn.1008-6358.2018.20170883

免疫抑制宿主并发肺部感染的临床诊治进展

Clinical status of immunocompromised host complicated with pulmonary infection

邝中淑 1赵英珺 1宋振举1

作者信息

  • 1. 复旦大学附属中山医院急诊科,上海200032
  • 折叠

摘要

Abstract

Pulmonary infections are the most common complications in immunocompromised host (ICH).The immune system of ICH was in inhibitory condition because of long-term use of immunosuppressive agents,such as glucocorticoids,antimetabolite medicine and alkylating agents.Therefore,compared with the immunocompetent host,the condition is more critically serious in ICH with more difficult diagnosis and treatment,and higher motality after pulmonary infections.Early identification of pathogens and early treatment are helpful for improving the prognosis and decreasing mortality.

关键词

免疫抑制宿主/肺部感染/机会性感染/诊治

Key words

immunocompromised host/pulmonary infections/opportunistic infections/diagnosis and treatment

分类

医药卫生

引用本文复制引用

邝中淑,赵英珺,宋振举..免疫抑制宿主并发肺部感染的临床诊治进展[J].中国临床医学,2018,25(1):137-140,4.

基金项目

国家自然科学基金(81471840,81171837,31471190,31671317),上海市中医药三年行动计划(ZY3-CCCX3-3018,ZHYY-ZXYJH-201615,2016ZB0202),上海市卫计委重要薄弱学科建设项目(20134Y023).Surppoted by National Natural Science Foundation of China(81471840,81171837,31471190,31671317),Three-Year Action Plan for Traditional Chinese Medicine in Shanghai(ZY3-CCCX3-3018,ZHYY-ZXYJH-201615,2016ZB0202),Shanghai Municipal Planning Commission of of Important Weak Construction Projects(20134Y023). (81471840,81171837,31471190,31671317)

中国临床医学

OACSTPCD

1008-6358

访问量0
|
下载量0
段落导航相关论文